Relationship of hepatotoxicity and the target tissue dose of decabrominated diphenyl ether in subacutely exposed Wistar rats

  • Marijana Ćurčić Department of Toxicology “Akademik Danilo Soldatović”, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia
  • Sladjana Tanasković Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia
  • Sanja Stanković Center for Medical Biochemistry, Clinical Center of Serbia, Belgrade, Serbia
  • Saša Janković Institute of Meat Hygiene and Technology, Belgrade, Serbia
  • Marko Antunović National Poison Control Center, Military Medical Academy, Belgrade, Serbia
  • Snežana Djordjević National Poison Control Center, Military Medical Academy, Belgrade, Serbia; Faculty of Medicine of the Military Medical Academy, University of Defence, Belgrade, Serbia
  • Vesna Kilibarda National Poison Control Center, Military Medical Academy, Belgrade, Serbia; Faculty of Medicine of the Military Medical Academy, University of Defence, Belgrade, Serbia
  • Slavica Vučinić National Poison Control Center, Military Medical Academy, Belgrade, Serbia; Faculty of Medicine of the Military Medical Academy, University of Defence, Belgrade, Serbia
  • Biljana Antonijević Department of Toxicology “Akademik Danilo Soldatović”, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia
Keywords: halogenated diphenyl ethers, liver, toxicity test, rats,

Abstract


Background/Aim. Based on numerous studies in animals, the most prominent toxic effects of decabrominated diphenyl ether (BDE-209) are observed in the liver, thyroid hormone homeostasis, reproductive and nervous systems. BDE-209 exhibits its toxic effects partly through the aryl hydrocarbon (Ah) receptor and consequent induction of hepatic microsomal enzymes. The aim of this study was to assess the hepatotoxic effect vs target tissue dose of BDE-209 in the subacutely orally exposed Wistar rats. Methods. Effects were examined on male Wistar rats, weighing 200–240 g, exposed to doses of 1,000, 2,000 or 4,000 mg BDE-209/kg body weight (bw)/day by gavage during 28 days. Animals were treated according to the decision of the Ethics Committee of the Military Medical Academy, No 9667-1/2011. Evaluation of the hepatotoxic effect was based on: relative liver weight water and food intake, biochemical parameters of liver function [aspartate amino transferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), gama glutamyl transferase (γ-GT)], and oxidative stress parameters in liver homogenates [malondialdehiyde (MDA), superoxide dismutase (SOD), -SH] and morphological and pathohistological changes in the liver. For the assessment of internal dose – response relationship, lower confidence limit of Benchmark dose (BMDL) of 5% or 10% i.e. BMDL5 or BMDL10, were calculated using PROAST software. Results. After the application of 1,000, 2,000 or 4,000 mg BDE-209/kg bw/day, the concentrations of BDE-209 measured in liver were 0.269, 0.569 and 0.859 mg/kg of liver wet weight, (ww) respectively. Internal doses correlated with external (r = 0.972; p < 0.05) according to equation: internal dose (mg BDE-209/kg of liver ww) = 0.0002 ´ external dose (mg/kg bw/day) + 0.0622. Hepatotoxicity was demonstrated based on significant increase in AST and γ-GT activities and the degree of histopathological changes. The lowest BMDL5 of 0.07228 mg BDE-209/kg of liver ww, correlating to external dose of 39 mg/kg/day, indicated the increase of AST activity as the most sensitive biomarker of BDE-209 hepatotoxicity in subacutely exposed rats. Conclusion. The results of the present work add up to the issue of BDE-209 toxicity profile with a focus on relationship between internal dose and hepatotoxicity. Critical internal dose for the effect on AST of 0.07 mg/kg of liver ww, corresponding to external dose of 39 mg/kg/day, is the lowest dose ever observed among the studies on BDE-209 hepatotoxicity. For the persistent substances with low absorption rate such as BDE-209, critical effect based on internal dose in majority of cases is considered as more precisely defined than the effect established based on external dose, particularly.

References

BSEF. Bromine Science and Environmental Forum. What are brominated flame retardants. 2004. Available from: http://www.bsefsite.com/bromine/what_are_bfrs/index.php

World Health Organization. Environmental Health Criteria 162. Brominated diphenyl ethers. International Program on Chemi-cal Safety. Geneva, Switzerland: World Health Organization; 1994.

World Health Organization. Environmental Health Criteria 192. Flame retardants: A general introduction. International Pro-gram on Chemical Safety. Geneva, Switzerland: World Health Organization; 1997.

Alaee M, Arias P, Sjödin A, Bergman A. An overview of com-mercially used brominated flame retardants, their applications, their use patterns in different countries/regions and possible modes of release. Environ Int 2003; 29(6): 683−9.

ATSDR. Toxicological Profile for Polybrominated Biphenyls and Polybrominated Diphenyl Ethers (PBBs and PBDEs). At-lanta, US: Agency for Toxic Substances and Disease Registry; 2004.

Environmental Protection Agency (EPA). Emerging Conta-minants-Polybrominated Diphenyl Ethers (PBDE) and Poly-brominated Biphenyls (PBB). 2008. Available from: ne-pis.epa.gov/Adobe/PDF/P1000L3S.PDF [cited 2008 April].

European Food Safety Authority. Scientific Opinion on Polybro-minated Diphenyl Ethers (PBDEs) in Food. EFSA J 2011; 9(5): 2156−430.

Ćurčić M, Antonijević B, Durgo K, Janković S, Jacević V. Toxicolog-ical relevance and potential risk due to polybrominated diphe-nylethers exposure. Arch Pharm 2010; 60(3): 311−22.

Alonso V, Linares V, Bellés M, Albina ML, Pujol A, Domingo JL, et al. Effects of BDE-99 on hormone homeostasis and bio-chemical parameters in adult male rats. Food Chem Toxicol 2010; 48(8−9): 2206−11.

Environmental Protection Agency (EPA). Toxicological Re-wiew of Decabromodiphenyl Ether (BDE-209). Washington, DC: Environmental Protection Agency; 2008. Available from: www.epa.gov/iris [cited 2008 June].

Erratico CA, Moffatt SC, Bandiera SM. Comparative oxidative metabolism of BDE-47 and BDE-99 by rat hepatic micro-somes. Toxicol Sci 2011; 123(1): 37−47.

Blanco J, Mulero M, Domingo JL, Sánchez DJ. Gestational exposure to BDE-99 produces toxicity through upregulation of CYP isoforms and ROS production in the fetal rat liver. Toxicol Sci 2012; 127(1): 296−302.

Ernest SR, Wade MG, Lalancette C, Ma Y, Berger RG, Robaire B, et al. Effects of chronic exposure to an environmentally relevant mixture of brominated flame retardants on the reproductive and thyroid system in adult male rats. Toxicol Sci 2012; 127(2): 496−507.

Morck A, Hakk H, Orn U, Klasson WE. Decabromodiphenyl ether in the rat: absorption, distribution, metabolism, and ex-cretion. Drug Metab Dispos 2003; 31(7): 900−7.

Bondy GS, Gaertner D, Cherry W, MacLellan E, Coady L, Arnold DL, et al. Brominated diphenyl ether (BDE) levels in liver, adipose, and milk from adult and juvenile rats exposed by ga-vage to the DE-71 technical mixture. Environ Toxicol 2011; 26(6): 677−90.

Ćurčić M, Janković S, Jaćević V, Stanković S, Vučinić S, Durgo K, et al. Combined effects of cadmium and decabrominated di-phenyl ether on thyroid hormones in rats. Arh Hig Rada Tok-sikol 2012; 63(3): 255−62.

Huwe JK, Hakk H, Birnbaum LS. Tissue distribution of poly-brominated diphenyl ethers in male rats and implications for biomonitoring. Environ Sci Technol 2008; 42(18): 7018−24.

Frederiksen M, Vorkamp K, Thomsen M, Knudsen EL. Human in-ternal and external exposure to PBDEs-a review of level and sources. Int J Hyg Envir Heal 2009; 212(2): 109−34.

Thuresson K, Bergman A, Jakobsson K. Occupational exposure to commercial decabromodiphenyl ether in workers manufactur-ing or handling flame-retarded rubber. Environ Sci Technol 2005; 39(7): 1980−6.

Bradford MM. A rapid and sensitive method for the quantita-tion of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248−54.

Misra HP, Fridovich I. The role of superoxide anion in the au-toxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 1972; 247(10): 3170−5.

Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959; 82(1): 70−7.

Slob W. Dose-Response Modeling of Continuous Endpoints. Tox Sci 2002; 66(2): 298−312.

European Food Safety Authority. Use of BMDS and PROAST software packages by EFSA Scientific Panels and Units for applying the Benchmark Dose (BMD) approach in risk as-sessment. EFSA J 2012; 113: 1−190.

Ćurčić M, Janković S, Jacević V, Stanković S, Vučinić S, Durgo K, et al. Use of proast software to assess the influence of decabro-minated diphenyl ether and/or cadmium on thyroid hormones homeostasis in rats. Arch Pharm 2012; 62(1): 1−13.

U.S. EPA (Environmental Protection Agency). Toxicological review of 2,2',3,3',4,4',5,5',6,6'-decabromodiphenyl ether (BDE-209). Integrated Risk Information System (IRIS). Washington DC: National Center for Environmental As-sessment; 2008. Available from: http://www.epa.gov/iris

Viberg H, Fredriksson A, Jakobsson E, Orn U, Eriksson P. Neu-robehavioral derangements in adult mice receiving decabro-minated diphenyl ether (PBDE 209) during a defined period of neonatal brain development. Toxicol Sci 2003; 76(1): 112−20.

Viberg H, Fredriksson A, Eriksson P. Changes in spontaneous behavior and altered response to nicotine in the adult rat, after neonatal exposure to the brominated flame retardant, de-cabrominated diphenyl ether (PBDE). Neurotoxicol 2007; 28(136): 209.

National Toxicology Program. NTP Toxicology and Carcinoge-nesis Studies of Decabromodiphenyl Oxide (CAS No. 1163-19-5) In F344/N Rats and B6C3F1 Mice (Feed Studies). Natl Toxicol Program Tech Rep Ser 1986; 309: 1−242.

Van der Ven LT, van de Kuil T, Leonards PE, Slob W, Cantón RF, Germer S, et al. A 28-day oral dose toxicity study in Wistar rats enhanced to detect endocrine effects of decabromodiphenyl ether (decaBDE). Toxicol Lett 2008; 179(1): 6−14.

Chen J, Liufu C, Sun W, Sun X, Chen D. Assessment of the neu-rotoxic mechanisms of decabrominated diphenyl ether (PBDE-209) in primary cultured neonatal rat hippocampal neurons includes alterations in second messenger signaling and oxidative stress. Toxicol Lett 2010; 192(3): 431−9.

Zhang C, Liu F, Liu X, Chen D. Protective effect of N-acetylcysteine against BDE-209-induced neurotoxicity in pri-mary cultured neonatal rat hippocampal neurons in vitro. Int J Dev Neurosci 2010; 28(6): 521−8.

He Y, Murphy MB, Yu RM, Lam MH, Hecker M, Giesy JP, et al. Effects of 20 PBDE metabolites on steroidogenesis in the H295R cell line. Toxicol Lett 2008; 176(3): 230−8.

Zhao A, Liu H, Zhang A, Wang X, Zhang H, Wang H. Effect of BDE-209 on glutathione system in Carassius auratus. Environ Toxicol Pharmacol 2011; 32(1): 35−9.

Matovic V, Dukic D, Plamenac-Bulat Z. Influence of increased cadmium intake on antioxidative defence system. Yugoslav Med Biochem 2004; 23: 117−26. (Serbian)

Published
2015/07/08
Section
Original Paper